Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells (Q37924625)

25 August 2017

1 reference

title

Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells (English)

1 reference

25 August 2017

mesenchymal stem cell

1 reference

Ênio José Bassi

1

1 reference

25 August 2017

Danilo Candido de Almeida

series ordinal

2

1 reference

25 August 2017

Pedro Manoel Mendes Moraes-Vieira

series ordinal

3

1 reference

25 August 2017

Niels Olsen Saraiva Câmara

series ordinal

4

1 reference

25 August 2017

1 June 2012

1 reference

Stem Cell Reviews and Reports

25 August 2017

1 reference

25 August 2017

8

1 reference

25 August 2017

2

1 reference

25 August 2017

329-342

1 reference

https://scigraph.springernature.com/pub.10.1007/s12015-011-9311-1

25 August 2017

0 references

cites work

Fibroblast Colony Formation from Monolayer Cultures of Blood Cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stem cells: biological characteristics and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

MSCs: Biological characteristics, clinical applications and their outstanding concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Functional differences between mesenchymal stem cell populations are reflected by their transcriptome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Interleukin-17-producing T helper cells in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

TGF-beta: from latent to active

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Structure and function of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Prostaglandins as modulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Human mesenchymal stem cell proliferation is regulated by PGE2 through differential activation of cAMP-dependent protein kinase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Nitric oxide synthases in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Regulation of the expression of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Interferon-gamma and NF-kappaB mediate nitric oxide production by mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Heme oxygenase-1/carbon monoxide: novel therapeutic strategies in critical care medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Immunoregulatory properties of heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Macrophage deactivation by interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Cell type-specific regulation of IL-10 expression in inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Interleukin-6: discovery of a pleiotropic cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Interleukin-6 and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Matrix metalloproteinases (MMPs) in health and disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Matrix metalloproteinases as modulators of inflammation and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Degradation of interleukin 1beta by matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

HLA-G-dependent suppressor cells: Diverse by nature, function, and significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Emerging topics and new perspectives on HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Monocyte chemoattractant protein-1 (MCP-1): an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Chemokines as regulators of T cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mechanisms involved in the therapeutic properties of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

The inflammatory chemokines CCL2 and CCL5 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Leukemia inhibitory factor and human embryo implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

The unsolved enigmas of leukemia inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Interleukin-10 From Transplanted Bone Marrow Mononuclear Cells Contributes to Cardiac Protection After Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9311-1

Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor

21 January 2018

1 reference

12 December 2020

Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells

1 reference

12 December 2020

Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression

1 reference

12 December 2020

HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells

1 reference

12 December 2020

10.1007/S12015-011-9311-1

Identifiers

DOI

1 reference

release_5kp7hwvisjevja7tv45phus7ay

25 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5kp7hwvisjevja7tv45phus7ay

24 November 2022

mapped directly with Wikidata item

1 reference